Total Assets Summary of Beijing Aosaikang Pharmaceutical Co., Ltd.

Beijing Aosaikang Pharmaceutical Co., Ltd.'s latest annual total assets in 2023 was 3.52 Billion CNY , up 3.21% from previous year.
Beijing Aosaikang Pharmaceutical Co., Ltd.'s latest quarterly total assets in 2024 Q3 was 3.95 Billion CNY , up 3.67% from previous quarter.
Beijing Aosaikang Pharmaceutical Co., Ltd. reported annual total assets of 3.41 Billion CNY in 2022, down -8.33% from previous year.
Beijing Aosaikang Pharmaceutical Co., Ltd. reported annual total assets of 3.72 Billion CNY in 2021, down -2.19% from previous year.
Beijing Aosaikang Pharmaceutical Co., Ltd. reported quarterly total assets of 3.95 Billion CNY for 2024 Q3, up 3.67% from previous quarter.
Beijing Aosaikang Pharmaceutical Co., Ltd. reported quarterly total assets of 3.68 Billion CNY for 2024 Q1, up 4.61% from previous quarter.

Annual Total Assets Chart of Beijing Aosaikang Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Total Assets of Beijing Aosaikang Pharmaceutical Co., Ltd. (2023 - 2011)

Year	Total Assets	Total Assets Growth
2023	3.52 Billion CNY	3.21%
2022	3.41 Billion CNY	-8.33%
2021	3.72 Billion CNY	-2.19%
2020	3.8 Billion CNY	3.14%
2019	3.69 Billion CNY	24.81%
2018	2.95 Billion CNY	241.37%
2017	866.57 Million CNY	25.49%
2016	690.57 Million CNY	-3.61%
2015	716.42 Million CNY	22.96%
2014	582.65 Million CNY	0.12%
2013	581.96 Million CNY	-3.78%
2012	604.82 Million CNY	35.54%
2011	446.21 Million CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	3.81 Billion CNY	3.49%
2024 Q3	3.95 Billion CNY	3.67%
2024 Q1	3.68 Billion CNY	4.61%
2023 Q1	3.34 Billion CNY	-2.09%
2023 Q4	3.52 Billion CNY	2.35%
2023 FY	3.52 Billion CNY	3.21%
2023 Q3	3.44 Billion CNY	6.48%
2023 Q2	3.23 Billion CNY	-3.28%
2022 Q1	3.67 Billion CNY	-1.25%
2022 FY	3.41 Billion CNY	-8.33%
2022 Q4	3.41 Billion CNY	-4.68%
2022 Q3	3.58 Billion CNY	-2.9%
2022 Q2	3.68 Billion CNY	0.3%
2021 FY	3.72 Billion CNY	-2.19%
2021 Q2	3.55 Billion CNY	-7.28%
2021 Q3	3.66 Billion CNY	3.06%
2021 Q4	3.72 Billion CNY	1.55%
2021 Q1	3.83 Billion CNY	0.79%
2020 Q4	3.8 Billion CNY	6.39%
2020 Q3	3.57 Billion CNY	10.31%
2020 Q1	3.55 Billion CNY	-3.62%
2020 FY	3.8 Billion CNY	3.14%
2020 Q2	3.24 Billion CNY	-8.81%
2019 Q2	3.38 Billion CNY	9.47%
2019 Q1	3.09 Billion CNY	4.58%
2019 Q4	3.69 Billion CNY	0.27%
2019 Q3	3.68 Billion CNY	8.72%
2019 FY	3.69 Billion CNY	24.81%
2018 Q1	833.32 Million CNY	-3.84%
2018 Q4	2.95 Billion CNY	247.18%
2018 FY	2.95 Billion CNY	241.37%
2018 Q3	852.07 Million CNY	1.4%
2018 Q2	840.34 Million CNY	0.84%
2017 Q1	668.49 Million CNY	-3.2%
2017 FY	866.57 Million CNY	25.49%
2017 Q4	866.57 Million CNY	-0.46%
2017 Q3	870.6 Million CNY	18.23%
2017 Q2	736.36 Million CNY	10.15%
2016 Q3	684.09 Million CNY	2.94%
2016 Q2	664.57 Million CNY	-2.2%
2016 Q1	679.48 Million CNY	-5.16%
2016 FY	690.57 Million CNY	-3.61%
2016 Q4	690.57 Million CNY	0.95%
2015 Q3	695.72 Million CNY	-8.36%
2015 FY	716.42 Million CNY	22.96%
2015 Q2	759.2 Million CNY	42.52%
2015 Q1	532.69 Million CNY	-8.57%
2015 Q4	716.42 Million CNY	2.98%
2014 FY	582.65 Million CNY	0.12%
2014 Q4	582.65 Million CNY	0.0%
2013 Q1	1.17 Billion CNY	19.89%
2013 Q2	1.17 Billion CNY	0.0%
2013 Q3	- CNY	-100.0%
2013 FY	581.96 Million CNY	-3.78%
2012 Q4	983.15 Million CNY	0.0%
2012 FY	604.82 Million CNY	35.54%
2011 FY	446.21 Million CNY	0.0%

Peer Total Assets Comparison of Beijing Aosaikang Pharmaceutical Co., Ltd.

Name	Total Assets	Total Assets Difference
Shenzhen Kangtai Biological Products Co., Ltd.	15.08 Billion CNY	76.64%
PharmaBlock Sciences (Nanjing), Inc.	5.1 Billion CNY	30.959%
Shandong Shanda Wit Science and Technology Co., Ltd.	5.19 Billion CNY	32.211%
Pacific Shuanglin Bio-pharmacy Co., LTD	8.63 Billion CNY	59.169%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	4.52 Billion CNY	22.044%
Jilin Aodong Pharmaceutical Group Co., Ltd.	32.26 Billion CNY	89.079%
Chengdu Huasun Technology Group Inc., Ltd.	2.13 Billion CNY	-65.171%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	3.01 Billion CNY	-16.685%
Hengkang Medical Group Co., Ltd.	6.08 Billion CNY	42.043%
Anhui Huangshan Capsule Co., Ltd.	1.1 Billion CNY	-219.457%
Walvax Biotechnology Co., Ltd.	15.58 Billion CNY	77.395%
Tianjin Ringpu Bio-Technology Co.,Ltd.	6.59 Billion CNY	46.575%
Anhui Fengyuan Pharmaceutical Co., Ltd.	4.39 Billion CNY	19.753%
Apeloa Pharmaceutical Co.,Ltd	12.76 Billion CNY	72.4%
Harbin Gloria Pharmaceuticals Co., Ltd	3.15 Billion CNY	-11.782%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	40.14 Billion CNY	91.223%
Hunan Hansen Pharmaceutical Co., Ltd.	2.33 Billion CNY	-50.82%
Xiamen Kingdomway Group Company	5.35 Billion CNY	34.175%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	6.33 Billion CNY	44.402%
Zhuhai Rundu Pharmaceutical Co., Ltd.	2.22 Billion CNY	-58.18%
Hainan Haiyao Co., Ltd.	7.36 Billion CNY	52.164%
Shenzhen Neptunus Bioengineering Co., Ltd.	32.3 Billion CNY	89.092%
Fujian Cosunter Pharmaceutical Co., Ltd.	1.61 Billion CNY	-118.267%
Huapont Life Sciences Co., Ltd.	30.72 Billion CNY	88.532%
Livzon Pharmaceutical Group Inc.	25.04 Billion CNY	85.93%
Honz Pharmaceutical Co., Ltd.	2.16 Billion CNY	-62.719%
Northeast Pharmaceutical Group Co., Ltd.	15.27 Billion CNY	76.928%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	19.2 Billion CNY	81.65%
Hainan Poly Pharm. Co., Ltd	6.28 Billion CNY	43.947%
Sunflower Pharmaceutical Group Co.,Ltd	6.88 Billion CNY	48.795%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	7.98 Billion CNY	55.877%
Kunming Longjin Pharmaceutical Co., Ltd.	631.63 Million CNY	-457.899%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	7.52 Billion CNY	53.14%
Zhejiang Yatai Pharmaceutical Co., Ltd.	1.42 Billion CNY	-146.533%
Zhejiang NHU Company Ltd.	39.15 Billion CNY	91.0%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	930.4 Million CNY	-278.747%
Jiuzhitang Co., Ltd.	5.32 Billion CNY	33.883%
Qianjiang Yongan Pharmaceutical Co., Ltd.	2.34 Billion CNY	-50.135%
Jinghua Pharmaceutical Group Co., Ltd.	3.18 Billion CNY	-10.64%
Hunan Er-Kang Pharmaceutical Co., Ltd	5.47 Billion CNY	35.685%
Yunnan Baiyao Group Co.,Ltd	53.78 Billion CNY	93.448%
ApicHope Pharmaceutical Co., Ltd	4.4 Billion CNY	20.008%
Shandong Wohua Pharmaceutical Co., Ltd.	1.14 Billion CNY	-207.842%
Jinling Pharmaceutical Company Limited	4.55 Billion CNY	22.561%
Beijing SL Pharmaceutical Co., Ltd.	6.27 Billion CNY	43.867%
Shanxi Zhendong Pharmaceutical Co.,Ltd	6.18 Billion CNY	42.984%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	2.12 Billion CNY	-65.828%
Huaren Pharmaceutical Co., Ltd.	5.16 Billion CNY	31.783%
Betta Pharmaceuticals Co., Ltd.	9.14 Billion CNY	61.475%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	1.33 Billion CNY	-163.635%
Changzhou Qianhong Biopharma CO.,LTD	2.76 Billion CNY	-27.396%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	8.52 Billion CNY	58.687%
Changjiang Pharmaceutical Group Co., Ltd.	3.44 Billion CNY	-2.267%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	1.54 Billion CNY	-128.421%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	5.26 Billion CNY	33.014%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	5.78 Billion CNY	39.04%
Guangdong Lifestrong Pharmacy Co., Ltd.	855.53 Million CNY	-311.892%
Huadong Medicine Co., Ltd	33.5 Billion CNY	89.484%
PKU HealthCare Corp.,Ltd.	2.43 Billion CNY	-44.523%
Hybio Pharmaceutical Co., Ltd.	3.27 Billion CNY	-7.527%
Shenzhen Weiguang Biological Products Co., Ltd.	2.87 Billion CNY	-22.494%
Fuan Pharmaceutical (Group) Co., Ltd.	5.97 Billion CNY	41.032%
Jiangsu Nhwa Pharmaceutical Co., LTD	7.32 Billion CNY	51.913%
Harbin Medisan Pharmaceutical Co., Ltd.	3.44 Billion CNY	-2.35%
Teyi Pharmaceutical Group Co.,Ltd	2.51 Billion CNY	-40.246%
Tus-Pharmaceutical Group Co., Ltd.	1.15 Billion CNY	-206.126%
LanZhou Foci Pharmaceutical Co.,Ltd.	2.52 Billion CNY	-39.388%
Changchun High-Tech Industries (Group) Inc.	30.74 Billion CNY	88.538%
Shanghai Kaibao Pharmaceutical CO.,Ltd	4.57 Billion CNY	23.054%
Shandong Xinhua Pharmaceutical Company Limited	8.35 Billion CNY	57.82%
Beijing Beilu Pharmaceutical Co., Ltd	2.81 Billion CNY	-24.986%
Dezhan Healthcare Company Limited	5.37 Billion CNY	34.483%
Beijing Science Sun Pharmaceutical Co., Ltd.	3.62 Billion CNY	2.714%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	11.83 Billion CNY	70.225%
Jinhe Biotechnology CO., LTD.	5.45 Billion CNY	35.387%
Baotou Dongbao Bio-Tech Co.,Ltd	2.74 Billion CNY	-28.514%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	1.43 Billion CNY	-145.896%
Tibet AIM Pharm. Inc.	927.74 Million CNY	-279.834%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	6.45 Billion CNY	45.438%
Nanjing Hicin Pharmaceutical Co., Ltd.	1.41 Billion CNY	-148.354%
Renhe Pharmacy Co., Ltd.	7.44 Billion CNY	52.666%
Wuhan Hiteck Biological Pharma Co.,Ltd	2.97 Billion CNY	-18.599%
Guizhou Xinbang Pharmaceutical Co., Ltd.	9.24 Billion CNY	61.883%
Dong-E-E-Jiao Co.,Ltd.	13.3 Billion CNY	73.517%
Jiangxi Synergy Pharmaceutical Co., Ltd.	3.22 Billion CNY	-9.388%
Chongqing Pharscin Pharmaceutical Co., Ltd.	1.85 Billion CNY	-90.331%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	6.99 Billion CNY	49.607%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	5.11 Billion CNY	31.139%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	7.34 Billion CNY	52.05%

Global Stocks Search

Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ)

Total Assets Summary of Beijing Aosaikang Pharmaceutical Co., Ltd.

Annual Total Assets Chart of Beijing Aosaikang Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Total Assets of Beijing Aosaikang Pharmaceutical Co., Ltd. (2023 - 2011)

Peer Total Assets Comparison of Beijing Aosaikang Pharmaceutical Co., Ltd.